Stocks fell sharply on Thursday as U.S.-China trade worries persisted with more companies suspending business with Chinese telecom giant Huawei.Marketsread more
A Ministry of Commerce spokesperson does not single out any U.S. action, but it's been a tense couple of weeks for the trade war.World Politicsread more
The e-mail's optimistic tone helped Tesla shares turn positive for the first time in seven days.Technologyread more
In a four-page letter sent Thursday morning, Warren and Ocasio-Cortez asked Mnuchin a series of questions about his advisory role in former Sears CEO Eddie Lampert's...Politicsread more
"For them to say that they don't work with the Chinese government is false," Secretary of State Mike Pompeo tells CNBC.Politicsread more
The yield on the 10-year Treasury note fell to its lowest level since 2017 as more traders grew confident in a longer U.S.-China conflict.Bondsread more
Prosecutors allege Stephen Calk, former president of Chicago-based Federal Savings Bank, loaned former Trump campaign chair Paul Manafort as much as $16 million in exchange...Politicsread more
A majority of American adults say they are living comfortably, according to an annual Federal Reserve study on financial well-being of households. But nearly a third still...Invest in You: Ready. Set. Grow.read more
At McDonald's annual shareholder meeting Thursday, executives said that the company is still monitoring plant-based meat substitutes.Restaurantsread more
The FAA's acting chief says airlines don't need to make more changes to their schedules after they removed the Boeing 737 Max from service through August. The FAA will review...Airlinesread more
Oil prices tumble as the market braces for a prolonged U.S.-China trade war and on signs the U.S. is willing to negotiate with Iran.Energy Commoditiesread more
Venture capitalist Chamath Palihapitiya backed away on Tuesday from his comment that IBM's Watson is a "joke" but insisted his artificial intelligence firm could still defeat Big Blue.
"We've been building a company for seven years now that's also doing something equally productive, and I would say better than IBM," the Social Capital founder and CEO said on CNBC's
"I would love to put us in a head-to-head to see how they do," he added, referring to
"I probably should have been more careful with my words," he said Tuesday.
But he said, "I have companies that we've been building and incubating for years in things like cancer and diabetes where we're bringing machine learning to the market where we've competed with competitors including IBM."
"There are a lot of people building extremely meaningful solutions who are probably getting somewhat out-marketed" by IBM, he added.
IBM responded to Palihapitiya's "joke" comments early Tuesday.
"Watson is not a consumer gadget but the A.I. platform for real business. Watson is in clinical use in the U.S. and 5 other countries. It has been trained on 6 types of cancers with plans to add 8 more this year," the company said in a statement. "Beyond oncology, Watson is in use by nearly half of the top 25 life sciences companies, major manufacturers for IoT applications, retail and financial services firms, and partners like GM, H&R
Palihapitiya said he would never invest in IBM. "I'm in the business of buying things that can grow in meaningful multiples ... over five to 10 year periods." But on the positive side, he said, "That's a business that I think can generate